Back to Search
Start Over
Late Vasopressor Administration in Patients in the ICU: A Retrospective Cohort Study.
- Source :
- CHEST; Aug2020, Vol. 158 Issue 2, p571-578, 8p
- Publication Year :
- 2020
-
Abstract
- <bold>Background: </bold>Little is known about the prevalence, predictors, and outcomes of late vasopressor administration which evolves after admission to the ICU.<bold>Research Question: </bold>What is the epidemiology of late vasopressor administration in the ICU?<bold>Study Design and Methods: </bold>We retrospectively studied a cohort of veterans admitted to the Veterans Administration ICUs for ≥ 4 days from 2014 to 2017. The timing of vasopressor administration was categorized as early (only within the initial 3 days), late (on day 4 or later and none on day 3), and continuous (within the initial 2 days through at least day 4). Regressions were performed to identify patient factors associated with late vasopressor administration and the timing of vasopressor administration with posthospitalization discharge mortality.<bold>Results: </bold>Among the 62,206 hospitalizations with at least 4 ICU days, late vasopressor administration occurred in 5.5% (3,429 of 62,206). Patients with more comorbidities (adjusted OR [aOR], 1.02 per van Walraven point; 95% CI, 1.02-1.03) and worse severity of illness on admission (aOR, 1.01 per percentage point risk of death; 95% CI, 1.01-1.02) were more likely to receive late vasopressor therapy. Nearly 50% of patients started a new antibiotic within 24 h of receiving late vasopressor therapy. One-year mortality after survival to discharge was higher for patients with continuous (adjusted hazard ratio [aHR], 1.48; 95% CI, 1.33-1.65) and late vasopressor administration (aHR, 1.26; 95% CI, 1.15-1.38) compared with only early vasopressor administration.<bold>Interpretation: </bold>Late vasopressor administration was modestly associated with comorbidities and admission illness severity. One-year mortality was higher among those who received late vasopressor administration compared with only early vasopressor administration. Research to understand optimization of late vasopressor therapy administration may improve long-term mortality. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00123692
- Volume :
- 158
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- CHEST
- Publication Type :
- Academic Journal
- Accession number :
- 144772629
- Full Text :
- https://doi.org/10.1016/j.chest.2020.02.071